Liver-targeted AAV vectors
The company collaborates to develop new AAV vectors specifically targeting the liver.
Source: LinkedIn company description · Retrieved October 13, 2026
Vivet Therapeutics develops gene therapy treatments for orphan diseases.
Vivet Therapeutics works with CIMA at the University of Navarra to optimize gene therapy.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company collaborates to develop new AAV vectors specifically targeting the liver.
Source: LinkedIn company description · Retrieved October 13, 2026
The company generates technologies to optimize gene delivery and long-term expression.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 6, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 21, 2026, September 27, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.